newdrugapprovals.org
MELOGLIPTIN
Melogliptin Phase III A DP-IV inhibitor potentially for treatment of type II diabetes. EMD-675992; GRC-8200 CAS No. 868771-57-7 4-fluoro-1-[2-[[(1R,3S)-3-(1,2,4-triazol-1-ylmethyl)cyclopentyl]amino…